Skip to main content
OpenTrials

Clinical trial condition

Severe Hypertriglyceridemia

Explore clinical trials studying Severe Hypertriglyceridemia. Study availability and eligibility vary by location and protocol.

20 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Severe Hypertriglyceridemia trial results

Completed

A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia

NCT05079919

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Accel Research Sites Network Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Velocity Clinical Research Chula Vista, California, United States
  • Diabetes/Lipid Management & Research Center Huntington Beach, California, United States
View all 209 locations
View Trial Details
Completed

A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia

NCT06555640

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Baoding No.1 Central Hospital Baoding, China
  • The First Affiliated Hospital of Baotou Medical College Baotou, China
  • Peking University First Hospital Beijing, China
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, China
View all 35 locations
View Trial Details
Completed

A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

NCT05552326

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Central Research Associates, Inc. Birmingham, Alabama, United States
  • Alabama Clinical Therapeutics, LLC Alabaster Birmingham, Alabama, United States
  • Onyx Clinical Research Peoria, Arizona, United States
  • NRC Research Institute Los Angeles, California, United States
View all 205 locations
View Trial Details
Completed

Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia

NCT04541186

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • 89Bio Clinical Study Site La Mesa, California, United States
  • 89Bio Clinical Study Site San Francisco, California, United States
  • 89Bio Clinical Study Site Clearwater, Florida, United States
  • 89Bio Clinical Study Site Greenacres City, Florida, United States
View all 48 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

NCT03001817

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Central Research Associates, Inc. Birmingham, Alabama, United States
  • Central Alabama Research Birmingham, Alabama, United States
  • Cahaba Research, Inc. Birmingham, Alabama, United States
  • Boyett Health Services Inc Hamilton, Alabama, United States
View all 220 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

NCT03011450

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Central Research Associates, Inc. Birmingham, Alabama, United States
  • Central Alabama Research Birmingham, Alabama, United States
  • Cahaba Research, Inc. Birmingham, Alabama, United States
  • Boyett Health Services Inc Hamilton, Alabama, United States
View all 241 locations
View Trial Details
Completed

A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia

NCT02944383

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +5 more
Locations
  • Appalachian Research Associates Fort Payne, Alabama, United States
  • Del Sol Research Mangagement, LLC Tucson, Arizona, United States
  • Westside Medical Associates of Los Angeles Beverly Hills, California, United States
  • Hope Clinical Research Canoga Park, California, United States
View all 49 locations
View Trial Details

Related conditions